The Effect of Albumin Level and Neutrophil Lymphocyte Ratio on Mortality and Recovery in Fournier's Gangrene

Albumin and NL Fournıer's Gangrene

Abstract

Background: Fournier's gangrene is a polymicrobial bacterial infection with high mortality and morbidity rates, and early diagnosis and treatment are crucial. The essentials of treatment are broad spectrum antibiotics and surgical debridement. In our study, we aimed to predict mortality more accurately in Fournier's gangrene.

Materials and Methods: Medical records of 60 patients operated for Fournier's gangrene in our clinic between 2016 and 2021 were retrospectively reviewed.

Results: 15% of the patients were of urogenital origin, 61.7% were colorectal, and 23.3% were idiopathic. The albumin value was lower in deceased individuals (27.35±4.66) compared to those who recovered (34.53±7.75) (p=0.001). A lower number of debridements and shorter hospital stay were observed in surviving patients (p<0.05). Being above the age of 59.50 was found to be a risk factor for mortality. An albumin value below 31.25 was found to be a risk factor for mortality. It was observed that the Neutrophil Lymphocyte ratio did not have a significant effect on mortality (p=0.733).

Conclusions: Serum albumin level was found to be a predictive value for mortality and recovery in patients with Fournier's gangrene. The Neutrophil Lymphocyte ratio did not have a significant effect on mortality and recovery in Fournier's gangrene.